Cargando…
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
BACKGROUND: Pancreatic cancer is a major cause of cancer-related mortality. The identification of effective biomarkers is essential in order to improve management of the disease. Yes-associated protein 1 (YAP1) is a downstream effector of the Hippo pathway, a signal transduction system implicated in...
Autores principales: | Zhou, Qimin, Bauden, Monika, Andersson, Roland, Hu, Dingyuan, Marko-Varga, György, Xu, Jianfeng, Sasor, Agata, Dai, Hua, Pawłowski, Krzysztof, Said Hilmersson, Katarzyna, Chen, Xi, Ansari, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017485/ https://www.ncbi.nlm.nih.gov/pubmed/32054505 http://dx.doi.org/10.1186/s12967-020-02254-7 |
Ejemplares similares
-
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
por: Zhou, Qimin, et al.
Publicado: (2019) -
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018) -
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019) -
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018) -
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
por: Bauden, Monika, et al.
Publicado: (2017)